China Predicts Windfall from Selling Monkeypox Test Kits

China-based diagnostic test makers hope to cash in heavily on the recent decision by the World Health Organization (WHO) to declare monkeypox a “public health emergency” as the WHO has requested bulk orders for testing kits. monkeypox tests from at least two of these manufacturers shortly after the declaration. , Chinese state global times reported on Tuesday.

The agency said at least two Chinese diagnostic test makers, Shanghai-based Liferiver and Taizhou-based Jiangsu Bioperfectus Technologies, received a significant number of orders for smallpox test kits in the hours after the announcement. from the WHO on 23 July that it now considers an outbreak of monkeypox to represent “a public health emergency of international concern”.

“A Liferiver manager surnamed Wang told the global times on Tuesday [July 26] that the orders came at about the same time the WHO declared a health emergency,” the paper relayed about Liferiver’s latest order for smallpox test kits.

“Life River […] received an urgent order for WHO monkeypox nucleic acid detection reagents, and the products will be supplied to 17 African countries, including Angola, Algeria, Ethiopia and Kenya,” the statement said. global times detailed.

The paper further revealed that Jiangsu Bioperfectus Technologies, another diagnostic test maker based in the eastern Chinese city of Taizhou, also “received a request from the WHO” for smallpox test kits shortly after the health body’s warning. UN public announcement on 23 July about the disease.

WHO Director-General Tedros Adhanom Ghebreyesus challenged a panel of WHO medical experts to declare monkeypox a “public health emergency” on July 23, despite acknowledging at the time that the disease posed a “moderate threat.” ” of global spread, at worst. The WHO said it had detected more than 16,000 smallpox cases in 75 countries and territories, along with five deaths from the disease, as of July 23. The global outbreak of the disease began in early May.

Fire Island, NY: A Northwell Health staff member holds the monkeypox vaccine, at Cherry Grove on Fire Island, New York, where the monkeypox vaccines were administered on July 14, 2022. ( Photo by James Carbone/Newsday RM via Getty Images)

Fire Island, NY: A Northwell Health staff member holds the smallpox vaccine, at Cherry Grove on Fire Island, New York, where the smallpox vaccines were administered on July 14, 2022. (Photo by James Carbone/Newsday RM via Getty Images)

Monkeypox is an infectious disease caused by the monkeypox virus, which is a “viral zoonosis” or a “virus transmitted to humans from animals,” according to the WHO.

“The smallpox virus is part of the same virus family as the smallpox virus, the virus that causes smallpox. Smallpox symptoms are similar to smallpox symptoms but milder, and smallpox is rarely fatal,” according to the US Centers for Disease Control and Prevention (CDC).

“While a vaccine has been approved for the prevention of smallpox, and the traditional smallpox vaccine also provides protection, these vaccines are not widely available and populations worldwide under the age of 40 or 50 no longer benefit from the protection offered. by previous smallpox vaccination programs,” the WHO noted on May 16.

Leave a Reply

Your email address will not be published.